Deutsche Welle examines Medicines for Malaria Venture’s (MMV) “Malaria Box,” which “holds 400 diverse compounds that kill the malaria parasite” and is distributed “free of charge to any researcher who wants it.” According to the news agency, “MMV aims to incite them to develop new, market-ready drugs based on one of the 400 compounds in the box.” DW adds, “Up to now, MMV has sent malaria boxes to 160 research groups in 27 countries, mainly to Europe and North America, but also to South Africa, India, Brazil and Uganda, for instance” (Osterath, 11/26).